A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

NCT02742649 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Fixed Combination
DRUG: Bimatoprost
DRUG: Timolol
DEVICE: Placebo Segment
DRUG: Timolol 0.5%

Sponsor

ForSight Vision5, Inc.